Alison T Stopeck

  • 10919 Citations
  • 41 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1982 2019

Filter
Article
2019

A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer

Segar, J. M., Reed, D., Stopeck, A. T., Livingston, R. B. & Chalasani, P., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access
irinotecan
Etoposide
Breast Neoplasms
Topoisomerase I Inhibitors
Type II DNA Topoisomerase

Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Stopeck, A. T., Brufsky, A., Kennedy, L., Bhatta, S., Bhowmik, D., Buchanan, J., Despiegel, N. & Hechmati, G., Jan 1 2019, (Accepted/In press) In : Journal of medical economics.

Research output: Contribution to journalArticle

Open Access
zoledronic acid
Cost-Benefit Analysis
Neoplasm Metastasis
Bone and Bones
Costs and Cost Analysis
2018
2 Citations (Scopus)

Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Kaufman, P. A., Wildiers, H., Freyer, G., Kemeny, M., Gonçalves, A., Jerusalem, G., Stopeck, A. T., Vrindavanam, N., Dalenc, F., Nanayakkara, N., Wu, B. & Pickett, C. A., Jan 1 2018, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Paclitaxel
Breast Neoplasms
Angiopoietin-1
Epidermal Growth Factor Receptor
Angiopoietin-2
5 Citations (Scopus)

Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI

Ding, J., Stopeck, A. T., Gao, Y., Marron, M. T., Wertheim, B. C., Altbach, M. I., Galons, J-P., Roe, D., Wang, F., Maskarinec, G., Thomson, C., Thompson, P. A. & Huang, C., Jan 1 2018, (Accepted/In press) In : Journal of Magnetic Resonance Imaging.

Research output: Contribution to journalArticle

Ionizing Radiation
Fats
Water
Breast Density
Breast
2017
7 Citations (Scopus)

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Thomson, C., Chow, H-H., Wertheim, B. C., Roe, D., Stopeck, A. T., Maskarinec, G., Altbach, M. I., Chalasani, P., Huang, C., Strom, M. B., Galons, J-P. & Thompson, P. A., May 30 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

Tamoxifen
Tumor Biomarkers
Randomized Controlled Trials
Placebos
Breast Neoplasms
148 Citations (Scopus)
Placebos
Breast Neoplasms
Disease-Free Survival
Therapeutics
Diarrhea
2016
4 Citations (Scopus)

A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI

Jha, A. K., Rodriguez, J. J. & Stopeck, A. T., 2016, (Accepted/In press) In : Magnetic Resonance in Medicine.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Linear Models
Signal-To-Noise Ratio
11 Citations (Scopus)

Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents

Lipton, A., Smith, M. R., Fizazi, K., Stopeck, A. T., Henry, D., Brown, J. E., Shore, N. D., Saad, F., Spencer, A., Zhu, L. & Warner, D. J., Dec 1 2016, In : Clinical Cancer Research. 22, 23, p. 5713-5721 9 p.

Research output: Contribution to journalArticle

Bone Density Conservation Agents
Bone Neoplasms
Bone Remodeling
Biomarkers
Neoplasm Metastasis
5 Citations (Scopus)

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer

Brown-Glaberman, U., Marron, M., Chalasani, P., Livingston, R. B., Iannone, M. E., Specht, J. & Stopeck, A. T., 2016, In : Disease Markers. 2016, 9810383.

Research output: Contribution to journalArticle

Carbonic Anhydrases
Breast Neoplasms
Plasmas
Therapeutics
Biomarkers
47 Citations (Scopus)

Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Smith, M. R., Shore, N., Martin, M., Vadhan-Raj, S., Brown, J. E., Richardson, G. E., Saad, F., Yardley, D. A., Zhou, K., Balakumaran, A. & Braun, A., Jan 1 2016, In : European Journal of Cancer. 53, p. 75-83 9 p.

Research output: Contribution to journalArticle

zoledronic acid
Neoplasm Metastasis
Bone and Bones
Denosumab
Neoplasms
17 Citations (Scopus)

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

Stopeck, A. T., Fizazi, K., Body, J. J., Brown, J. E., Carducci, M., Diel, I., Fujiwara, Y., Martín, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J. & Braun, A., Jan 1 2016, In : Supportive Care in Cancer. 24, 1, p. 457-458 2 p.

Research output: Contribution to journalArticle

247 Citations (Scopus)

Extending aromatase-inhibitor adjuvant therapy to 10 years

Goss, P. E., Ingle, J. N., Pritchard, K. I., Robert, N. J., Muss, H., Gralow, J., Gelmon, K., Whelan, T., Strasser-Weippl, K., Rubin, S., Sturtz, K., Wolff, A. C., Winer, E., Hudis, C., Stopeck, A. T., Beck, J. T., Kaur, J. S., Whelan, K., Tu, D. & Parulekar, W. R., Jul 21 2016, In : New England Journal of Medicine. 375, 3, p. 209-219 11 p.

Research output: Contribution to journalArticle

letrozole
Aromatase Inhibitors
Placebos
Confidence Intervals
Breast Neoplasms
31 Citations (Scopus)

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases

von Moos, R., Body, J. J., Egerdie, B., Stopeck, A. T., Brown, J., Fallowfield, L., Patrick, D. L., Cleeland, C., Damyanov, D., Palazzo, F. S., Marx, G., Zhou, Y., Braun, A., Balakumaran, A. & Qian, Y., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1327-1337 11 p.

Research output: Contribution to journalArticle

Bone Neoplasms
Analgesics
Neoplasm Metastasis
Pain
Bone and Bones
1 Citation (Scopus)

Pathophysiology of tumour-induced microangiopathic haemolytic anaemia

Chalasani, P., Segar, J. M., Marron, M. & Stopeck, A. T., Jan 7 2016, In : BMJ Case Reports. 2016, 213521.

Research output: Contribution to journalArticle

Hemolytic Anemia
Circulating Neoplastic Cells
Thrombotic Thrombocytopenic Purpura
Neoplasms
Hemolytic-Uremic Syndrome
13 Citations (Scopus)

Phase II study of metformin for reduction of obesity-associated breast cancer risk: A randomized controlled trial protocol

Martinez, J. A., Chalasani, P., Thomson, C., Roe, D., Altbach, M. I., Galons, J-P., Stopeck, A. T., Thompson, P. A., Villa-Guillen, D. E. & Chow, H-H., Jul 19 2016, In : BMC Cancer. 16, 1, 500.

Research output: Contribution to journalArticle

Metformin
Clinical Protocols
Randomized Controlled Trials
Obesity
Breast Neoplasms
44 Citations (Scopus)

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Stopeck, A. T., Fizazi, K., Body, J. J., Brown, J. E., Carducci, M., Diel, I., Fujiwara, Y., Martín, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J. & Braun, A., Jan 1 2016, In : Supportive Care in Cancer. 24, 1, p. 447-455 9 p.

Research output: Contribution to journalArticle

zoledronic acid
Prostatic Neoplasms
Breast Neoplasms
Safety
Osteonecrosis
2015
18 Citations (Scopus)

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Chalasani, P., Marron, M., Roe, D., Clarke, K., Iannone, M. E., Livingston, R. B., Shan, J. S. & Stopeck, A. T., Jul 1 2015, In : Cancer Medicine. 4, 7, p. 1051-1059 9 p.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
Paclitaxel
Breast Neoplasms
Phosphatidylserines
Endothelial Cells
17 Citations (Scopus)

Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models

Chen, L. Q., Howison, C. M., Perry, C. S., Stopeck, A. T., Malm, S. W., Pagel, M. M. & Baker, A. F., May 1 2015, In : Leukemia and Lymphoma. 56, 5, p. 1432-1439 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Lymphoma
Cell Line
Heterografts
Acidosis
25 Citations (Scopus)

Automated Breast Segmentation of Fat and Water MR Images Using Dynamic Programming

Rosado-Toro, J. A., Barr, T., Galons, J-P., Marron, M. T., Stopeck, A. T., Thomson, C., Thompson, P., Carroll, D., Wolf, E., Altbach, M. I. & Rodriguez, J. J., Feb 1 2015, In : Academic Radiology. 22, 2, p. 139-148 10 p.

Research output: Contribution to journalArticle

Breast
Fats
Water
Cluster Analysis
Pectoralis Muscles
8 Citations (Scopus)

Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis

Stephen, R. M., Jha, A. K., Roe, D. J., Trouard, T. P., Galons, J. P., Kupinski, M. A., Frey, G., Cui, H., Squire, S., Pagel, M. M., Rodriguez, J. J., Gillies, R. J. & Stopeck, A. T., Dec 1 2015, In : Magnetic Resonance Imaging. 33, 10, p. 1267-1273 7 p.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Biomarkers
Magnetic resonance
Liver
Neoplasm Metastasis
79 Citations (Scopus)

EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer

Yardley, D. A., Weaver, R., Melisko, M. E., Saleh, M. N., Arena, F. P., Forero, A., Cigler, T., Stopeck, A. T., Citrin, D., Oliff, I., Bechhold, R., Loutfi, R., Garcia, A. A., Cruickshank, S., Crowley, E., Green, J., Hawthorne, T., Yellin, M. J., Davis, T. A. & Vahdat, L. T., May 10 2015, In : Journal of Clinical Oncology. 33, 14, p. 1609-1619 11 p.

Research output: Contribution to journalArticle

Glycoproteins
Breast Neoplasms
Antibodies
Triple Negative Breast Neoplasms
Pharmaceutical Preparations
52 Citations (Scopus)

Hypocalcaemia in patients with metastatic bone disease treated with denosumab

Body, J. J., Bone, H. G., De Boer, R. H., Stopeck, A. T., Van Poznak, C., Damião, R., Fizazi, K., Henry, D. H., Ibrahim, T., Lipton, A., Saad, F., Shore, N., Takano, T., Shaywitz, A. J., Wang, H., Bracco, O. L., Braun, A. & Kostenuik, P. J., Aug 8 2015, In : European Journal of Cancer. 51, 13, p. 1812-1821 10 p., 9488.

Research output: Contribution to journalArticle

Hypocalcemia
Bone Diseases
zoledronic acid
Calcium
Bone and Bones
7 Citations (Scopus)

Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series

Chahal, J., Stopeck, A. T., Clarke, K., Livingston, R. B. & Chalasani, P., Sep 27 2015, In : Neurological Sciences. 36, 9, p. 1691-1693 3 p.

Research output: Contribution to journalArticle

Meningeal Carcinomatosis
Thiotepa
Breast Neoplasms
Methotrexate
Therapeutics
21 Citations (Scopus)

The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease

Diel, I. J., Body, J. J., Stopeck, A. T., Vadhan-Raj, S., Spencer, A., Steger, G., Von Moos, R., Goldwasser, F., Feng, A. & Braun, A., 2015, In : European Journal of Cancer. 51, 11, p. 1467-1475 9 p.

Research output: Contribution to journalArticle

Bone Diseases
Hypercalcemia
zoledronic acid
Neoplasms
Multiple Myeloma
2014
11 Citations (Scopus)
exemestane
Estradiol
Hormones
Breast Neoplasms
Disease Progression

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (Support Care Cancer (2013) 21, (3497-3507) DOI: 10.1007/s00520-013-1932-2)

Von Moos, R., Body, J. J., Egerdie, B., Stopeck, A. T., Brown, J. E., Damyanov, D., Fallowfield, L. J., Marx, G., Cleeland, C. S., Patrick, D. L., Palazzo, F. G., Qian, Y., Braun, A. & Chung, K., 2014, In : Supportive Care in Cancer. 22, 8, p. 2309-2310 2 p.

Research output: Contribution to journalArticle

zoledronic acid
Double-Blind Method
Quality of Life
Neoplasm Metastasis
Bone and Bones
8 Citations (Scopus)

Isolation of viable cancer cells in antibody-functionalized microfluidic devices

Zheng, X., Jiang, L., Schroeder, J., Stopeck, A. T. & Zohar, Y., Mar 1 2014, In : Biomicrofluidics. 8, 2, 24119.

Research output: Contribution to journalArticle

Lab-On-A-Chip Devices
microfluidic devices
antibodies
Microfluidics
Antibodies
43 Citations (Scopus)

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: Results from a multicenter, randomized, controlled trial of vatreptacog alfa

Lentz, S. R., Ehrenforth, S., Abdul Karim, F., Matsushita, T., Weldingh, K. N., Windyga, J., Mahlangu, J. N., Weltermann, A., de Paula, E., Cerqueira, M., Zupancic-Salek, S., Katsarou, O., Economou, M., Nemes, L., Boda, Z., Santagostino, E., Tagariello, G., Hanabusa, H., Fukutake, K., Taki, M. & 33 others, Shima, M., Gorska-Kosicka, M., Serban, M., Andreeva, T., Savic, A., Elezovic, I., Mahlangu, J., Tsay, W., Shen, M., Chuansumrit, A., Angchaisuksiri, P., Kavakli, K., Kupesiz, A., Sasmaz, I., Madan, B., Rangarajan, S., Giangrande, P., Saxena, K., Lentz, S., Recht, M., Kempton, C., Barrett, J., Young, G., Quon, D., Stopeck, A. T., Lin, J., Ameri, A., Kaicker, S., Kuriakose, P., Obzut, D., Wang, M., Ortiz, I. & Sori, A., 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1244-1253 10 p.

Research output: Contribution to journalArticle

Hemophilia A
Randomized Controlled Trials
Hemorrhage
Hemophilia B
Safety
2013

Authors' response to letter to the editor.

Stopeck, A. T., Henry, D., Dansey, R., Qian, Y., Cong, Z. & Arellano, J., 2013, In : Journal of Medical Economics. 16, 2, p. 262-263 2 p.

Research output: Contribution to journalArticle

Bone Density Conservation Agents
Imidazoles
Antibodies, Monoclonal, Humanized
Bone Neoplasms
Diphosphonates
2 Citations (Scopus)
Diffusion Magnetic Resonance Imaging
Physics
Medicine
5 Citations (Scopus)

Impact of denosumab on bone mass in cancer patients

Brown-Glaberman, U. & Stopeck, A. T., 2013, In : Clinical Pharmacology: Advances and Applications. 5, p. 117-129 13 p.

Research output: Contribution to journalArticle

Bone and Bones
Neoplasms
Therapeutics
Diphosphonates
Denosumab
52 Citations (Scopus)

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid

Von Moos, R., Body, J. J., Egerdie, B., Stopeck, A. T., Brown, J. E., Damyanov, D., Fallowfield, L. J., Marx, G., Cleeland, C. S., Patrick, D. L., Palazzo, F. G., Qian, Y., Braun, A. & Chung, K., Dec 2013, In : Supportive Care in Cancer. 21, 12, p. 3497-3507 11 p.

Research output: Contribution to journalArticle

zoledronic acid
Double-Blind Method
Quality of Life
Neoplasm Metastasis
Bone and Bones
85 Citations (Scopus)

Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid

Cleeland, C. S., Body, J. J., Stopeck, A. T., Von Moos, R., Fallowfield, L., Mathias, S. D., Patrick, D. L., Clemons, M., Tonkin, K., Masuda, N., Lipton, A., De Boer, R., Salvagni, S., Oliveira, C. T., Qian, Y., Jiang, Q., Dansey, R., Braun, A. & Chung, K., Feb 15 2013, In : Cancer. 119, 4, p. 832-838 7 p.

Research output: Contribution to journalArticle

zoledronic acid
Bone Neoplasms
Double-Blind Method
Breast Neoplasms
Neoplasm Metastasis
2 Citations (Scopus)

Reply to Araki et al.

Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H. & Braun, A. H., Jun 2013, In : European Journal of Cancer. 49, 9, p. 2266-2268 3 p.

Research output: Contribution to journalArticle

Bone Density Conservation Agents
Imidazoles
Antibodies, Monoclonal, Humanized
Bone Neoplasms
Diphosphonates
14 Citations (Scopus)

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

Matza, L. S., Cong, Z., Chung, K., Stopeck, A. T., Tonkin, K., Brown, J., Braun, A., Van Brunt, K. & McDaniel, K., Jan 2013, In : Patient Preference and Adherence. 7, p. 855-865 11 p.

Research output: Contribution to journalArticle

Subcutaneous Infusions
Subcutaneous Injections
Intravenous Infusions
Neoplasm Metastasis
Bone and Bones
2012
45 Citations (Scopus)
Vincristine
B-Cell Lymphoma
Prednisone
Non-Hodgkin's Lymphoma
Doxorubicin
30 Citations (Scopus)

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer

Rugo, H. S., Jo Chien, A., Franco, S. X., Stopeck, A. T., Glencer, A., Lahiri, S., Arbushites, M. C., Scott, J., Park, J. W., Hudis, C., Nulsen, B. & Dickler, M. N., Jul 2012, In : Breast Cancer Research and Treatment. 134, 1, p. 13-20 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Confidence Intervals
Breast Neoplasms
Circulating Neoplastic Cells
Endothelial Cells
65 Citations (Scopus)

Bone-related complications and quality of life in advanced breast cancer: Results from a randomized phase III trial of denosumab versus zoledronic acid

Martin, M., Bell, R., Bourgeois, H., Brufsky, A., Diel, I., Eniu, A., Fallowfield, L., Fujiwara, Y., Jassem, J., Paterson, A. H. G., Ritchie, D., Steger, G. G., Stopeck, A. T., Vogel, C., Fan, M., Jiang, Q., Chung, K., Dansey, R. & Braun, A., Sep 1 2012, In : Clinical Cancer Research. 18, 17, p. 4841-4849 9 p.

Research output: Contribution to journalArticle

zoledronic acid
Quality of Life
Breast Neoplasms
Bone and Bones
Hypercalcemia
43 Citations (Scopus)

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Stopeck, A. T., Rader, M., Henry, D., Danese, M., Halperin, M., Cong, Z., Qian, Y., Dansey, R. & Chung, K., Aug 2012, In : Journal of Medical Economics. 15, 4, p. 712-723 12 p.

Research output: Contribution to journalArticle

zoledronic acid
Cost-Benefit Analysis
Neoplasm Metastasis
Bone and Bones
Quality-Adjusted Life Years
367 Citations (Scopus)

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

Saad, F., Brown, J. E., Van Poznak, C., Ibrahim, T., Stemmer, S. M., Stopeck, A. T., Diel, I. J., Takahashi, S., Shore, N., Henry, D. H., Barrios, C. H., Facon, T., Senecal, F., Fizazi, K., Zhou, L., Daniels, A., Carrière, P. & Dansey, R., May 2012, In : Annals of Oncology. 23, 5, p. 1341-1347 7 p.

Research output: Contribution to journalArticle

Osteonecrosis
Jaw
zoledronic acid
Neoplasm Metastasis
Bone and Bones
31 Citations (Scopus)

Prevalence of depression in adults with haemophilia

Iannone, M. E., Pennick, L., Tom, A., Cui, H., Gilbert, M., Weihs, K. L. & Stopeck, A. T., Nov 2012, In : Haemophilia. 18, 6, p. 868-874 7 p.

Research output: Contribution to journalArticle

Hemophilia A
Depression
Health
Risk-Taking
Unemployment
28 Citations (Scopus)

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors

Brown-Glaberman, U. & Stopeck, A. T., 2012, In : Biologics: Targets and Therapy. 6, p. 89-99 11 p.

Research output: Contribution to journalArticle

Neoplasm Metastasis
Bone and Bones
Diphosphonates
Osteoclasts
Neoplasms
314 Citations (Scopus)

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., Bilynskyy, B., Charu, V., Beuzeboc, P., Rader, M., Viniegra, M., Saad, F., Ke, C., Braun, A. & Jun, S., Nov 2012, In : European Journal of Cancer. 48, 16, p. 3082-3092 11 p.

Research output: Contribution to journalArticle

zoledronic acid
Bone and Bones
Disease Progression
Prostatic Neoplasms
Neoplasm Metastasis
11 Citations (Scopus)

Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standard

Jha, A. K., Kupinski, M. A., Rodriguez, J. J., Stephen, R. M. & Stopeck, A. T., Jul 7 2012, In : Physics in Medicine and Biology. 57, 13, p. 4425-4446 22 p.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Gold
Magnetic Resonance Spectroscopy
29 Citations (Scopus)

The role of targeted therapy and biomarkers in breast cancer treatment

Stopeck, A. T., Brown-Glaberman, U., Wong, H. Y., Park, B. H., Barnato, S. E., Gradishar, W. J., Hudis, C. A. & Rugo, H. S., Oct 2012, In : Clinical and Experimental Metastasis. 29, 7, p. 807-819 13 p.

Research output: Contribution to journalArticle

Biomarkers
Breast Neoplasms
Triple Negative Breast Neoplasms
Medical Oncology
Therapeutics
3 Citations (Scopus)

Weighing bone-targeted treatment options for patients with solid tumours and skeletal complications from metastatic disease

Fallowfield, L., von Moos, R., Costa, L., Stopeck, A. T., Clemons, M., Clarke, N., Braun, A. & Chung, K., Jul 2012, In : European Oncology and Haematology. 8, 3, p. 148-155 8 p.

Research output: Contribution to journalArticle

Bone Diseases
Bone and Bones
Pain
Neoplasms
Activities of Daily Living
2011
1 Citation (Scopus)

Decreased bone mineral density in adult patients with Hemophilia: Clinical significance, prevalence and risk factors

Broum-Glaberman, U., Kissee, M. C., Damiano, M. L., Roe, D. & Stopeck, A. T., Oct 2011, In : Journal of Coagulation Disorders. 3, 1, p. 27-33 7 p.

Research output: Contribution to journalArticle

Hemophilia A
Bone Density
Osteoporosis
Joints
Hepacivirus
2 Citations (Scopus)

How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?

Gralow, J. R., Lipton, A. & Stopeck, A. T., Sep 10 2011, In : Journal of Clinical Oncology. 29, 26, p. 3591-3592 2 p.

Research output: Contribution to journalArticle

Bone Density Conservation Agents
Bone Neoplasms
Osteoclasts
Breast Neoplasms
286 Citations (Scopus)

HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab

Modi, S., Stopeck, A. T., Linden, H., Solit, D., Chandarlapaty, S., Rosen, N., D'Andrea, G., Dickler, M., Moynahan, M. E., Sugarman, S., Ma, W., Patil, S., Norton, L., Hannah, A. L. & Hudis, C., Aug 1 2011, In : Clinical Cancer Research. 17, 15, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

tanespimycin
Breast Neoplasms
Therapeutic Human Experimentation
Karnofsky Performance Status
Protein Stability
44 Citations (Scopus)

Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors

Gerber, D. E., Stopeck, A. T., Wong, L., Rosen, L. S., Thorpe, P. E., Shan, J. S. & Ibrahim, N. K., Nov 1 2011, In : Clinical Cancer Research. 17, 21, p. 6888-6896 9 p.

Research output: Contribution to journalArticle

Phosphatidylserines
Pharmacokinetics
Monoclonal Antibodies
Safety
Neoplasms